Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Signal Transduction and Memory—SCOP Scuppers MAPK Pathway
31 March 2007. In neurons, mitogen-activated protein kinase (MAPK) regulates a variety of signal transduction pathways, including those involved in long-term memory and survival, so anything that modulates MAPK signaling could have important consequences for the working of the brain. In the March 23 Cell, Daniel Storm and colleagues at the University of Washington, Seattle, show that a protein called SCOP attenuates MAPK signaling in the hippocampus and must be proteolytically degraded before certain long-term memories can be formed. The work introduces a new level of complexity into the molecular biology of memories. It may also have implications for the pathology of Alzheimer disease since MAPK activity has been linked to tau and γ-secretase phosphorylation.

SCOP, or suprachiasmatic nucleus (SCN) circadian oscillatory protein, was first discovered because it undergoes rhythmic fluctuations in the SCN, a tiny region of the brain that houses the circadian clock. While SCOP does not undergo these oscillations in other regions of the brain, it is present, and Kimiko Shimizu and colleagues at Osaka University, Japan, showed that in PC-12 cells, it binds to K-ras, preventing stimulation of MAPK by neurotrophins (Shimizu et al., 2003). Now, working in Storm’s lab in Seattle, first author Shimizu and colleagues have delved deeper into SCOP biology to ask what role, if any, the protein may play in MAPK-mediated pathways in the hippocampus, a region of the brain that plays a crucial role in learning and memory and that is badly damaged by AD pathology.

Because MAPK-stimulated transcription through the cAMP response element (CRE) is necessary for memory consolidation, the researchers began by looking at the effects of SCOP on a CRE-mediated reporter system. Shimizu and colleagues found that the protein is expressed in the hippocampus and that in cultured hippocampal cells it attenuates expression of a CRE-driven luciferase gene. When they co-transfected hippocampal cells with reporter and SCOP expression constructs, brain-derived neurotrophic factor (BDNF)-induced luciferase expression was reduced by about 80 percent. In contrast, when they silenced SCOP expression by RNAi, CRE-dependent luciferase activity increased about fourfold, even in the absence of BDNF.

The findings suggest that SCOP regulates CRE-driven transcription, raising the question of how SCOP itself is regulated. Finding no evidence that the protein is phosphorylated, the researchers asked if its degradation might relieve suppression of CRE promoters. When they looked at SCOP levels in BDNF-treated primary hippocampal neurons, they found that the protein underwent rapid cycling. Five minutes after BDNF was added SCOP, levels fell by about half, but fully recovered after about 60 minutes. Test tube analysis of SCOP degradation revealed a calcium-dependent process, suggesting that caspases, the proteasome, or calpain might be the proteolytic culprit. Shimizu found that neither caspase-3 nor proteasome inhibitors prevented SCOP degradation. The calpain inhibitor calpeptin did, however, and since they also found that calpain is activated in the neurons on addition of BDNF, the findings suggest that calpain-induced degradation may provide short-term relief from SCOP suppression of MAPK signals.

What relevance might all of this have on neuronal activity in general and on memory in particular? To address this, Shimizu and colleagues trained mice in a novel object recognition paradigm of learning and memory. They found that this training led to a small (16 percent), though significant drop in SCOP levels after 5 minutes and an increase in MAPK activity. Furthermore, when they generated a mouse strain with a tetracycline-inducible SCOP expression system and tested it in the learning and memory paradigm, they found that induction of SCOP completely prevented the animals from learning new objects.

The findings link calcium influx, SCOP degradation, MAPK control of CRE-driven transcription, and learning and memory. “We hypothesize that calpain-catalyzed degradation of SCOP in response to activity-dependent Ca2+ increases is required for activation of MAPK during formation of hippocampus-dependent memory,” write the authors. SCOP regulation may have other far-reaching ramifications, too. MAPK has been implicated in tau (see Lambourne at al., 2005), presenilin (see Kim et al., 2006), and neurofilament phosphorylation (see Veeranna et al., 2004), which may all be important in AD. “Although this study focused on regulation of SCOP in hippocampal neurons and its relationship to memory formation, the data have broad implications because of the central role played by MAPK and CRE-mediated transcription in neuroplasticity,” write the authors.—Tom Fagan.

Reference:
Shimizu K, Phan T, Mansury IM, Storm DR. Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory. Cell. 2007, Mar 23; 128:1219-1229.

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad